BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, June 3, 2026
Home
»
Topics
»
Disease categories and therapies
» Urology
Urology
RSS
Auspex Pharma patents new beta3-adrenoceptor modulators
Jan. 21, 2011
Ono Pharma claims new agents for urinary incontinence
Jan. 20, 2011
FP-1097 is effective in phase II trial in female incontinence and overactive bladder
Jan. 14, 2011
Apricus Biosciences grants Bracco rights to market Vitaros in Italy
Jan. 3, 2011
Phase I/II data reported on OMS-201 in patients undergoing ureteroscopy
Dec. 30, 2010
Antares files NDA for Anturol gel in overactive bladder
Dec. 30, 2010
TRPV4 antagonists hold promise for the treatment of bladder dysfunction
Dec. 24, 2010
Recordati and Nymox sign licensing agreement for NX-1207 in BPH
Dec. 20, 2010
Merck & Co. divulges novel beta3-adrenoceptor agonists
Dec. 13, 2010
Long-term phase III study confirms efficacy of avanafil for erectile dysfunction
Dec. 7, 2010
Previous
1
2
…
114
115
116
117
118
119
120
121
122
…
318
319
Next